Pink, Isabell
Hennigs, Jan K.
Ruhl, Louisa
Sauer, Andrea
Boblitz, Lennart
Huwe, Marie
Fuge, Jan
Falk, Christine S.
Pietschmann, Thomas
de Zwaan, Martina
Prasse, Antje
Kluge, Stefan
Klose, Hans
Hoeper, Marius M.
Welte, Tobias
Funding for this research was provided by:
Förderstiftung MHHPlus Hannover
COVID-19 –Research Network of the State of Lower Saxony (COFONI), Ministry of Science and Culture of Lower Saxony, Germany (COFONI-2FF4, COFONI-2FF4, 14-76103-184 CORONA-13/20, COFONI-2FF4)
Deutsches Zentrum für Infektionsforschung (project 07_913)
Medizinische Hochschule Hannover (MHH)
Article History
Received: 22 August 2023
Accepted: 9 October 2023
First Online: 4 November 2023
Declarations
:
: IP has received fees for lectures from Boehringer Ingelheim and AstraZeneca outside the submitted work; JKH has received grants, contracts, and/or fees for lectures and/or consultations from Boehringer Ingelheim, Janssen, Pfizer, and Years outside the submitted work; JF reports personal fees/speaker honoraria from AstraZeneca outside the submitted work; AP reports speaker honoraria from Boehringer Ingelheim, Novartis, Gilead, Amgen outside the submitted work; MMH has received fees for lectures and/or consultations from Acceleron, AOP Health, Bayer, Ferrer, Janssen, and MSD outside the submitted work; TW has received fees for lectures and/or consultations from AstraZeneca, Berlin-Chemie, Boehringer, GSK, Insmed, Janssen, Moderna, Novartis, Pfizer, Roche, Sanofi Aventis, and Shionogi outside the submitted work; SK has received fees for lectures and/or consultations from Gilead, MSD, Shionogi, and Pfizer outside the submitted work; AP, LB, LR, CSF, MdZ, and TP have nothing to disclose.
: This study was approved by the institutional review board at Hannover Medical School (#9226_BO_K_2020) and by the ethic committee of the Hamburg Chamber of Physicians (Hamburger Ärztekammer) (#PV7298 and PV7343).